20 articles
Most genetic variants explain only a few percent of nutritional differences between people, yet companies market expensive personalized plans.
A key fat metabolism protein works inside cell nuclei to keep fat tissue healthy — its absence causes fat loss, not gain.
New AI-discovered peptide mimics Ozempic's weight loss effects but targets only the brain's appetite center, avoiding nausea and muscle loss.
Scientists mapped a two-pathway gut-brain alarm that shifts appetite from sugar to protein when essential amino acids drop.
A protein thought only to burn fat secretly protects fat cell health from inside the nucleus, reshaping obesity and metabolic disease research.
Stanford researchers found genetic variants in ~10% of people that blunt GLP-1 drug effectiveness, pointing toward precision diabetes care.
Scientists found astrocytes, not just neurons, control when you feel full after eating through a newly discovered glucose-sensing pathway.
New research reveals genetic 'GLP-1 resistance' affects 1 in 10 people, explaining why popular diabetes and weight-loss drugs fail for some patients.
Genetic testing for health risks has a 40% false-positive rate and often outperformed by lifestyle factors. Here's what the evidence shows.
New research reveals GLP-1 drugs like Ozempic deliver stronger results for 'see-food' eaters than those who eat due to stress or emotions.
A proteomics study tracking 3,000 blood proteins reveals fasting's deepest benefits emerge only after 72 hours without food.
Beyond calories and vitamins lies a vast world of unmapped food chemicals that may quietly drive disease risk and healthy aging.
Scientists found dragonflies see deep red light like humans do, opening doors for new light-based therapies that work inside the body.
Experts say the next era of obesity care pairs GLP-1 medications with precision medicine, endoscopic procedures, and surgery for lasting results.
New research suggests eating unprocessed meat could help people with Alzheimer's risk genes maintain better brain function.
New research reveals how hormone FGF21 activates brain circuits to boost metabolism and reverse obesity, offering alternative to GLP-1 drugs.
A Mass General Brigham trial found multivitamin users aged slower on 5 epigenetic clocks, with the biggest gains in those aging fastest.
A newly identified trigger in brown fat activates a hidden calorie-burning pathway and may unlock new treatments for bone disease.
New research reveals fructose acts as a metabolic signal promoting fat storage, insulin resistance, and chronic disease risk.
A simple scoring system based on plant food percentage in your diet may be the best predictor of weight and health outcomes.
